Last reviewed · How we verify

NCT03409484

Effects of Concord Grape Juice Alone on Glycemia, Appetite and Cognitive Function in Healthy Adults

Completed NA Last updated 5 November 2020
What this trial tests

NA trial testing Concord Grape Juice in Glycemic Response in 40 participants. Completed in 20 September 2019.

Timeline
10 October 2018
Primary endpoint
28 March 2019
20 September 2019

Quick facts

Lead sponsorPurdue University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposebasic science
Enrollment40
Start date10 October 2018
Primary completion28 March 2019
Estimated completion20 September 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Purdue University

Who can join

Adults 25 to 60, any sex, with Glycemic Response or Appetitive Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assess the impact of 100% grape juice on postprandial glycemic response and subsequent appetite, food intake and cognitive function.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of Concord grape juice flavor intensity and phenolic compound content on glycemia, appetite and cognitive function in adults with excess body weight: a randomized double-blind crossover trial.
    Coelho OGL, Alfenas RCG, Debelo H, Wightman JD, et al · · 2021 · cited 5× · PMID 34698750 · DOI 10.1039/d1fo02049h

Verify or expand the search:

Other trials of Concord Grape Juice

Trials testing the same drug.

Other recruiting trials for Glycemic Response

Currently open trials in the same condition.

Other Purdue University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03409484.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing